SIAP
ABBV icon

Sterling Investment Advisors (Pennsylvania)’s AbbVie ABBV Stock Holding History

Sterling Investment Advisors (Pennsylvania)’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-16,894
Closed -$2.69M – 139
2023
Q1 		$2.69M Sell
16,894
-143
-0.8% -$21.9K 0.91% 37
2022
Q4 		$2.75M Sell
17,037
-43
-0.3% -$6.59K 0.99% 34
2022
Q3 		$2.29M Sell
17,080
-54
-0.3% -$7.75K 0.86% 39
2022
Q2 		$2.62M Buy
17,134
+606
+4% +$92.6K 0.9% 34
2022
Q1 		$2.68M Buy
16,528
+1
+0% +$145 0.76% 44
2021
Q4 		$2.24M Sell
16,527
-430
-3% -$50.8K 0.63% 53
2021
Q3 		$1.83M Sell
16,957
-430
-2% -$49.1K 0.54% 61
2021
Q2 		$1.96M Buy
17,387
+8
+0% +$901 0.57% 59
2021
Q1 		$1.88M Buy
17,379
+8
+0% +$856 0.61% 57
2020
Q4 		$1.86M Buy
17,371
+433
+3% +$41.6K 0.63% 57
2020
Q3 		$1.48M Sell
16,938
-643
-4% -$60.5K 0.57% 58
2020
Q2 		$1.73M Buy
17,581
+2,736
+18% +$241K 0.72% 42
2020
Q1 		$1.13M Buy
14,845
+507
+4% +$43.2K 0.6% 53
2019
Q4 		$1.27M Sell
14,338
-295
-2% -$24.5K 0.58% 51
2019
Q3 		$1.11M Sell
14,633
-1,491
-9% -$102K 0.57% 52
2019
Q2 		$1.17M Sell
16,124
-53
-0.3% -$4.17K 0.6% 53
2019
Q1 		$1.3M Sell
16,177
-843
-5% -$69K 0.66% 51
2018
Q4 		$1.57M Sell
17,020
-223
-1% -$19.6K 0.92% 37
2018
Q3 		$1.63M Sell
17,243
-20
-0.1% -$1.9K 0.86% 35
2018
Q2 		$1.6M Buy
17,263
+863
+5% +$84.3K 0.94% 32
2018
Q1 		$1.55M Sell
16,400
-400
-2% -$43.9K 0.95% 33
2017
Q4 		$1.63M Hold
16,800
– – 1.01% 30
2017
Q3 		$1.49M Sell
16,800
-650
-4% -$49.5K 0.99% 34
2017
Q2 		$1.26M Sell
17,450
-90
-0.5% -$6.05K 0.84% 41
2017
Q1 		$1.14M Buy
17,540
+250
+1% +$15.7K 0.82% 42
2016
Q4 		$1.08M Buy
+17,290
New +$1.06M 0.87% 39

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sterling Investment Advisors (Pennsylvania)'s ABBV Position: Q2 2023 in Review

Sterling Investment Advisors (Pennsylvania) sold out of AbbVie (ABBV) in Q2 2023, closing a stake of 16,894 shares — an estimated $2.69M sold.

Sterling Investment Advisors (Pennsylvania) first reported a position in ABBV in Q4 2016 and held it in 26 quarters. The position peaked at $2.75M in Q4 2022. 3,077 funds tracked by Wall St. Rank hold ABBV as of Q2 2023.

  • Sterling Investment Advisors (Pennsylvania) reported no remaining AbbVie position as of Q2 2023 after selling out during the quarter.
  • Sterling Investment Advisors (Pennsylvania) sold 16,894 AbbVie shares in Q2 2023, an estimated $2.69M.
  • Sterling Investment Advisors (Pennsylvania) first reported a position in AbbVie in Q4 2016 and held it in 26 quarters.
  • Sterling Investment Advisors (Pennsylvania)'s AbbVie position peaked at $2.75M in Q4 2022.
  • 3,077 funds tracked by Wall St. Rank held AbbVie as of Q2 2023.

Based on Sterling Investment Advisors (Pennsylvania)'s 13F filing for Q2 2023, filed 3 Aug 2023.